Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-01-23
2010-11-30
Henley, III, Raymond J (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S210010, C514S210080
Reexamination Certificate
active
07842683
ABSTRACT:
Administration of β-Lactam compounds, including β-lactam antibiotics and β-lactamase inhibitors provides significant neurotropic effects in warm-blooded vertebrates evidence inter alia by anxiolytic and anti-aggressive behavior modification and enhanced cognition. Therapeutic methods for using such compounds and their pharmaceutical formulations are described.
REFERENCES:
patent: 4138486 (1979-02-01), Narisada et al.
patent: 4234579 (1980-11-01), Barth
patent: 4268503 (1981-05-01), Imanaka et al.
patent: 4302447 (1981-11-01), Horrobin
patent: 4349672 (1982-09-01), Montavon et al.
patent: 4529722 (1985-07-01), Matsumura et al.
patent: 4594247 (1986-06-01), Brier
patent: 5698221 (1997-12-01), Patel et al.
patent: 5763603 (1998-06-01), Trickes
patent: 5795877 (1998-08-01), Jackson et al.
patent: 5824662 (1998-10-01), Slusher et al.
patent: 5827537 (1998-10-01), Palepu et al.
patent: 5863536 (1999-01-01), Jackson et al.
patent: 5880112 (1999-03-01), Jackson et al.
patent: 5905076 (1999-05-01), Singh et al.
patent: 5912242 (1999-06-01), Pevarello et al.
patent: 5968915 (1999-10-01), Jackson et al.
patent: 5977090 (1999-11-01), Slusher et al.
patent: 6004946 (1999-12-01), Slusher et al.
patent: 6015809 (2000-01-01), Zhu et al.
patent: 6017903 (2000-01-01), Slusher et al.
patent: 6204260 (2001-03-01), Bruns et al.
patent: 6426342 (2002-07-01), Koppel
patent: 6489319 (2002-12-01), Koppel et al.
patent: 6610681 (2003-08-01), Koppel
patent: 6627625 (2003-09-01), Koppel
patent: 7166626 (2007-01-01), Koppel
patent: 2001/0011085 (2001-08-01), Alpegiani et al.
patent: 2002/0002159 (2002-01-01), Koppel
patent: 2002/0002876 (2002-01-01), Bezet
patent: 2002/0028761 (2002-03-01), Koppel et al.
patent: 2002/0049187 (2002-04-01), Bruns et al.
patent: 2004/0014739 (2004-01-01), Koppel
patent: 2007/0093466 (2007-04-01), Koppel
patent: 2007/0249523 (2007-10-01), Koppel et al.
patent: 2008/0176825 (2008-07-01), Koppel et al.
patent: 2008/0200447 (2008-08-01), Koppel
patent: 1508977 (1978-04-01), None
patent: 95/20980 (1995-08-01), None
patent: WO9520980 (1995-08-01), None
patent: 97/10247 (1997-03-01), None
patent: WO9710247 (1997-03-01), None
patent: 97/35839 (1997-10-01), None
patent: WO9735839 (1997-10-01), None
patent: 97/48400 (1997-12-01), None
patent: 98/13044 (1998-04-01), None
patent: 98/13046 (1998-04-01), None
patent: 98/32766 (1998-07-01), None
patent: WO9832766 (1998-07-01), None
patent: 98/45256 (1998-10-01), None
patent: 98/47906 (1998-10-01), None
patent: 98/53812 (1998-12-01), None
patent: 99/33847 (1999-07-01), None
patent: 99/36403 (1999-07-01), None
patent: 00/62067 (2000-10-01), None
patent: 01/12171 (2001-02-01), None
patent: 01/12184 (2001-02-01), None
patent: 02/063954 (2002-08-01), None
patent: 02/064087 (2002-08-01), None
patent: 02/064147 (2002-08-01), None
patent: 02/102378 (2002-12-01), None
patent: 2005/020904 (2005-03-01), None
Batueva, I.V., et al., “Effect of Penicillin on the Synaptic Activity of Isolated Spinal Cord Motor Neurons in the Lamprey,” Neir ofiziologiia, vol. 24, No. 2, 1992, English Abstract, 2 pages.
Bashir, Z.I., et al., “N-methyl-D-aspartate Receptors and.the Enhancement of Somatosensory Evoked Potentials in Penicillin Epileptogenesis in Rats,” Physiological Society, 1987, 1 page.
Horn, E., et al., “Time Course of Interictal EEG Patterns Induced by a Penicillin Injection Into the Olfactory Cortex,” Pharmacology Biochemistry & Behavior, vol. 40, 1991, pp. 351-357.
Home, A.L., et al., “The Pharmacology of Recombinant GABAAReceptors Containing Bovine αl, β1, γ2LSub-Units Stably Transfected Into Mouse Fibroblast L-Cells,” Br. J. Pharmacol. vol. 107, 1992, pp. 732-737.
Kalueff, A.V., et al., “Penicillins and Their Derivatives: Antiulcer/Antistress Properties?,” Neuropsychoharmacology, vol. 10, No. 3S, Part 2, 1994, 1 page.
Orwar, O., et al., “Increased Intra- and Extracellular Concentrations of γ-Glutamylglutamate and Related Dipeptides in the Ischemic Rat Striatum: Involvement of γ-Glutamyl Transpeptidase,” Journal of Neurochemistry, vol. 63, 1994, pp. 1371-1376.
Serval, V., et al., “Competitive Inhibition of N-Acetylated-α-Linked Acidic Dipeptidase Activity by N-Acetyl-L-Aspartyl-β-Linked L-Glutamate,” Journal of Neurochemistry, vol. 55, 1990, pp. 39-46.
Varga, V., et al., “Endogenous γ-L-Glutamyl and β-L-Aspartyl Peptides and Excitatory Aminoacidergic Neurotransmission in the Brain,” Neuropeptides, vol. 27, 1994, pp. 19-26.
Nilsson, B. at al., “β-Lactam Analogues of Oxotremorine 3- and 4-Methyl-Substituted 2-Azetidinones,”,J. Med. Chem., vol. 33, 1990, pp. 580-584.
Duijn, H.V. et al., “Action of Penicillin on Inhibitory Processes in the Cat's Cortex,” Brain Res., vol. 53, 1973, pp. 470-476.
Meyer, H. et al., “Convulsant Actions of Penicillin: Effects on Inhibitory Mechanisms,” vol. 53, 1973, 477-482.
Hochner, B. et al., “Penicillin Decreases Chloride Conductance in Crustacean Muscle: A Model for the Epileptic Neuron,” Brain Res., vol. 107, 1976, pp. 85-103.
Chemomordik, A.B., Klin. Med. 1980, vol. 2, pp. 102-105.
Pickles, H.G., et al., “Antagonism by Penicillin of Gamma-Aminobutyric Acid Depolarization at Presynaptic Sites in Rat Olfactory Cortex and Cuneate Nucleus In Vitro,” Neuropharmacology, vol. 19, 1980, pp. 35-38.
Sanger, D.J., “GABA and the Behavioral Effects of Anxiolytic Drugs,” Life Sciences, vol. 36, 1985, pp. 1503-1513.
Chow, P. et al., “Convulsant Doses of Penicillin Shorten the Lifetime of GABA-Induced Channels in Cultured Central Neurones,” Br. J. Pharmac., vol. 88, 1986, pp. 541-547.
Kaluev, A.V. et al., “Behavioral Effects of Penicillin in a Test for Anxiety in Rats,” Bulletin of Experimental Biology and Medicine, vol. 120, No. 10, 1995, pp. 984-986.
Jackson, P.F. et al., “Design, Synthesis, and Biological Activty of a Potent Inhibitor of the Neuropeptidase N-Acetylated Alpha-Linked Acidic Dipeptidase,” J. Med. Chem., vol. 39. No. 2, 1996, pp. 619-622.
Ungerer, A. et al., “Gamma-L-Glutamyl-L-Aspartate Induces Specific Deficits in Long-Term Memory and Inhibits [3H]Glutamate Binding on Hippocampal Membranes,” Brain Res., vol. 446, 1988, pp. 205-211.
Reynolds, E.F. “Martindale, The Extra Pharmocopoeia,”Royal Pharmaceutical Society, London, col. 2-3, 1996, XP-002161510, p. 211.
Passani, et al., “N-acetylaspartylglutamate, N-acetylaspartate, and N-acetylated alpha-linked acidic dipeptidase in human brain and their alterations in Huntington and Alzheimer diseases,”Molecular and Chemical Neuropathology, vol. 31, No. 2, 1997, pp. 97-118.
Macknin, M.L., “Behavioral changes after amoxicillin-clavulanate,” letter,Pediatric Infectious Disease Journal, vol. 6, No. 9, 1987, pp. 873-874.
Tsai, G., et al., “Abnormal Excitatory Neurotransmitter Metabolism in Schizophrenic Brains”,Archives of General Psychiatry, vol. 52, No. 10, 1995, pp. 829-836.
Pangalos, M. N., et al. “Isolation and expression of novel human glutamate carboxypeptidases with N-acetylated alpha-linked acidic dipeptidase and dipeptidyl peptidase IV activity,”Journal of Biological Chemistry, vol. 274, No. 13, 1999, pp. 8470-8483.
Drummond, J. et al., “Synthesis of a Cognition Enhancing Beta-Lactam Fused Gamma-Lactam,”Terahedron Ltrs, vol. 28, No. 44, 1987, pp. 5245-5248.
Kabanov, A. et al., “The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles,”FEBS Letters, 07908, vol. 258, No. 2, 1989, pp. 343-345.
Iwamoto et al, English abstract from Japanese Patent JP360193982A from JPO database, 1985.
Zhang, W. et al., “The GCP II (NAALADase) Inhibitor GPI 5693 Prevents the Nerve Conduction Velocity Deficit and Morphological Changes Associated with Diabetes in the Type 1 Diabetic BB/WOR Rat,”Society for Neuroscience
Gollin Michael A.
Haddaway Keith G.
Henley, III Raymond J
Revaax Pharmaceuticals, LLC
Venable LLP
LandOfFree
Neurotherapeutic compositions and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neurotherapeutic compositions and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neurotherapeutic compositions and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4244859